We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Denying Obese Patients Knee Replacements Groundless

By HospiMedica International staff writers
Posted on 29 Aug 2008
A new study has found that the benefits of total knee arthroplasty (TKA) are apparent in obese as well as non-obese patients, and there seems no justification for withholding surgery from obese patients solely on the grounds of their body mass index (BMI).

Researchers at the University of Southampton (United Kingdom) and the University of Bristol (United Kingdom) followed-up 325 patients from three English health districts approximately six years after TKA, along with 363 controls selected from the general population. More...
Baseline data, collected by interview and examination, included age, sex, comorbidity, BMI, functional status, and preoperative radiographic severity of osteoarthritis. Functional status at follow-up was assessed by a postal questionnaire. Predictors of change in physical function were then analyzed by linear regression.

The results showed that at the beginning of the follow-up, the patients said they had significantly worse mobility than those in the comparison group, scoring an average of 20 compared with 89. However, by the end of the study, there was a stark contrast in mobility among those who had and had not had the surgery; mobility score rose three points among those who had had surgery, but fell 36 points among those who had not had a TKA. In addition, among those over the age of 75 who had not had the surgery, mobility score fell 40 points.

Improvement in physical function tended to be greater in patients with more severe radiological disease of the knee, and was less in those who reported pain at other joint sites at baseline. When the researchers restricted their analysis to participants who were obese, the improvements persisted, and BMI did not appear to be a significant factor in this improvement. The study was published in July 2008, issue of the Annals of the Rheumatic Diseases (ARD).

"The long term improvement in physical function that we observed in patients who have undergone knee replacement surgery is striking when set against the decline that occurred in the comparison group,” concluded lead author physiotherapist Janet Cushnaghan, MSC, MCSP, of the University of Southampton, and colleagues. "These benefits extend to patients who are obese and, provided appropriate selection criteria are applied with regard to fitness for surgery, there seems no justification for withholding knee replacement surgery from patients who are obese.”

Related Links:
University of Southampton
University of Bristol


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.